Loading clinical trials...
Loading clinical trials...
This trial aimed to assess efficacy and safety of cetuximab when given in combination with chemotherapy compared with chemotherapy alone in Chinese participants with recurrent and/or metastatic squamo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck KGaA, Darmstadt, Germany
NCT03485209 · Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, and more
NCT02296684 · Cancer of Head and Neck, Head and Neck Cancer, and more
NCT03509012 · Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Non-Small-Cell Lung, and more
NCT02113878 · Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, and more
NCT01606566 · Recurrent Head and Neck Cancer, Carcinoma, Squamous Cell of Head and Neck
Research site
Darmstadt
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions